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cardiac function in patients with acute MI and received primary percutaneous coronary
intervention.
Methods: This retrospective cohort study included patients presented during January
2008 to March 2011 to Peking University Third Hospital with ST-segment elevation
MI. All patients received successful primary PPCI.
Results: MPV was measured serially from admission to day 7 after MI. In 375
patients, MPV reached its peak value (10.161.05 fL) at the admission, and then
reduced by 16% within the 24 hours. Patients with poorer ventricular function,
estimated by high Killip Class (2, n¼96), had higher MPV values at all-time
points studied. By logistic regression model and after adjusting for related
confounders, high MPV remained as an independent predictor of Killip Class
score2 [odds ratio (OR) ¼ 1.873, 95% conﬁdence interval (CI) 1.373-2.673;
p ¼ 0.001].
Conclusions: MPV undergoes rapid and dynamic changes during the acute phase of
MI, and was higher in patients with high Killip Class, suggesting a predictive value of
MPV in ventricular dysfunction and clinical outcome of acute phase of MI.
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Objectives: To search independent inﬂuencing factors of total ischemic time in pri-
mary percutaneous coronary intervention.
Methods: ST segment elevation myocardial infarction patients who received primary
percutaneous coronary intervention between January 2009 and December 2012 in
Nanjing Drum-tower hospital were retrospectively studied. Total ischemic time was
estimated as the sum of pain onset to door time and door to balloon time. Patients were
divided into four groups according to the quartiles of total ischemic time. Patients’
demographic information, clinical information, total ischemic time and its components
were compared among the four groups. Multi-variable linear regression analysis was
employed to reveal the independent infuencing factors.
Results: There was difference in senior education level, medical insurance status,
transferring from another hospital, atypical chest pain, pain onset to door time, door to
balloon time and total ischemic time among the four groups. Transferring from
another hospital was found to be the only independent inﬂuencing factor of total
ischemic time. Besides, pain onset to door time contributed more than door to balloon
time to the prolongation of total ischemic time in this study.
Conclusions: Transferring from another hospital independently impacts total
ischemic time, and it increases total ischemic time maily by prolonging pain onset to
door time.
GW25-e4107
The Effect of Rate of Acute Myocardial Infarction Dissolved Thrombosis in
Dongzhimen Hospital According To Health Education In Haiyuncang
Community
Shen Xiaoxu
Cardiology Department, Dongzhimen Hospital Afﬁliated to Beijing University of
Chinese Medicine
Objectives: To study the effect of rate of acute Myocardial Infarction Dissolved
Thrombosis in Dongzhimen Hospital according to Health Education in Haiyuncang
Community.
Methods: By reviewing the past three years of Dongzhimen Hospital patients
admitted with acute myocardial infarction rate and the rate of thrombolytic therapy.
Get patients’ Statistics of time from the onset to the administration into CCU. After
the health education of the community patient for one year to improve the degree
of emphasis on community-related knowledge for chest pain and related symptoms
of AMI to train community physicians with acute myocardial infarction throm-
bolytic therapy time awareness and referral consciousness, intermediate links as
short as possible, get statistics of time from the onset of illness to the CCU and
hospitalization rate of AMI patients within one year and the rate of thrombolytic
therapy. In the end we compare and analyze the data with the previous three years’
statistically.
Results: The time of patients from the onset to the entry to CCU was signiﬁcantly
shorter after the community health education of the patient for one year. The rate of
thrombolytic therapy for acute myocardial infarction patients has improved signiﬁ-
cantly. Thrombolytic therapy rate compared with the average of the previous three
years are statistically signiﬁcant X2 ¼2.3634 p <0.05.
Conclusions: Health Education in Haiyuncang Community to improve the degree of
emphasis on community-related knowledge for chest pain and related symptoms of
AMI can improve rate of Acute Myocardial Infarction Dissolved Thrombosis in
Dongzhimen Hospital has important signiﬁcance in saving patients dying of
myocardial.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CGW25-e4197
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Objectives: To study the relationship between Cys C and vulnerable plaque of cor-
onary artery disease.
Methods: 360 patients accepted coronary angiography were consecutive enrolled our
research, including 60 cases without any coronary stenosis as control guoup. The
coronary artery lesions was divided into typeI, II and III plaque group by the
morphology of atherosclerotic plaque. Serum Cys C, hs-CRP and lipid were measured
in 60 control subjects, 85 typeIplaque, 139 type II plaque and 76 type III plaque. Then
we compare Cys C, hs-CRP and lipid level of four groups using One-Way ANOVA.
Results: Cys C , low density lipoprotein cholesterol (LDL-C) and hs-CRP were
signiﬁcantly higher in the patients with type II than those in control, typeIand III group
(P<0.05), Based on multiple stepwise logistic regression analysis, Cys C, hs-CRP,
LDL-C were independent risk factors of vulnerable plaque, respectively, the relative
ratio (RR) were 2.759, 1.453, 1.708 in type II plaque group. The level of Cys C was
correlated positively with hs-CRP in type II group (r¼0.635, P<0.01), but there are
not same correlationship between Cr and hs-CRP.
Conclusions: Elevated levels of serum Cys C may have a correlation with the
occurrence of coronary vulnerable plaques, which may lead to changes in plaque
stability through direct effects and inﬂammatory factors.
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Objectives: Aim to investigate whether ticagrelor is associated with signiﬁcant
improved platelet activity after PCI in patients with clopidogrel resistance suffering
with acute coronary syndrome and to evaluate its efﬁcacy and safety.
Methods: Consecutive patients admitted to Department of Cardiology in the General
Hospital of Armed Police were enrolled between December 2012 and January
2014.They were patients with a diagonosis of NSTE-ACS who were scheduled for
PCI.Blood samples were obtained by venipuncture of the antecubital vein respec-
tively between 6-12h after the clopidogrel 600mg.The VASP phosphorylation
analysis of blood collection was performed with BD FACSCalibur ﬂow cytometer.
According to the deﬁnition of High Platelet Reactivity (PRI50%) accepted inter-
nationally which was correlated well with clinical prognosis of patients undergoing
PCI, conﬁrmed by several studies and ROC curve analysis, 76 patients with high
platelet reactivity (PRI50%) were included, and were randomized to clopidogrel
75mg qd or clopidogrel 150mg qd or ticagrelor 90mg bid.The VASP assay was
performed 2days, 7days and 28days after PCI respectively. Meanwhile, the MACE,
bleeding events and adverse reactions were recorded.All patients received aspirin
100mg qd.
Results: (1) 365 consecutive patients admitted for PCI were prospectively screened
for inclusion in this study. A total of 289 patients were not included.Therefore, 76
patients were included and randomized to clopidogrel 75mg qd group (n¼26) or
clopidogrel 150mg qd group (n¼25) or ticagrelor 90mg bid group (n¼25). 2 patients
in clopidogrel 75mg qd group, 3 patients in clopidogrel 150mg qd group and 2 pa-
tients ticagrelor 90mg bid group were drop-outs, which refused to test the platelet
function. Ultimately, there were 24, 22 and 23 patients respectively ﬁnished the whole
study. (2) After 28 days antiplatelet treatment, the PRI decreased in three groups,
meanwhile, it was signiﬁcantly lower in patients receiving ticagrelor 90mg bid group
compared with other two groups.The PRI of clopidogrel 75mg qd group, clopidogrel
150mg qd group, ticagrelor 90mg bid group were 52.1%11.2, 45.5%9.7, 22.4%
9.4, respectively (P<0.001).After pairwise comparison they all have statistic differ-
ence (P¼0.03, P<0.001, P<0.001). (3) After 28 days antiplatelet treatment, the
compliance rate of PRI of clopidogrel 75mg qd group, clopidogrel 150mg qd group,
ticagrelor 90mg bid group were 45.8%, 68.2%, 100%, respectively (P<0.001).After
pairwise comparison clopidogrel 75mg qd group and clopidogrel 150mg qd group
have no statistic difference (P¼0.1>0.0125).Ticagrelor 90mg bid group has statistic
difference compared with other two groups (P<0.001, P¼0.003). (4) During 28 days
follow-up, 2 cardiovascular adverse events and 2 minor bleeding in clopidogrel 75mg
qd group;1 cardiovascular adverse events and 2 minor bleeding in clopidogrel 150mg
qd group; 4 minor bleeding in ticagrelor 90mg bid group, not resulting in a statis-
tically difference (MACE:P¼0.4;minor bleeding:P¼0.6), with no major bleedings
recorded.
Conclusions: (1) Ticagrelor 90mg bid and clopidogrel 150mg qd can obviously
suppress platelet reactivity by VASP phosphorylation analysis compared with clopi-
dogrel 75mg qd group, and ticagrelor 90mg bid was more signiﬁcantiy. (2) There is a
tendency that ticagrelor 90mg bid and clopidogrel 150mg qd can reduce MACE in
ACS patients with clopidogrel resistance. (3) Ticagrelor 90mg bid and clopidogrel
150mg qd did not increase bleeding events.ardiovascular Disease Clinical Research C137
